<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20121107011398N15</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-03</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of pressure versus volume control ventilation in one lung ventilation</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of two Pressure and Volume control ventilation during one lung ventilation in thoracic surgeries on the gas exchanges and the respiratory mechanical variables</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-01-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60041</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: This is a randomized clinical trial in which patients are assigned to one of two study groups using simple randomization methods in order of their entry. The randomization unit is personal and using a lottery drawing method, the third person draws blindly a sealed paper on which one of two groups' name is written. Thus we could achieve a concealed random sequence for allocation of patients as the process of lottery is repeated for each new patient entered, Blinding description: Due to this fact that the study is performed under general anesthesia, the participating patients do not know the group and type of intervention. There is no possibility for blinding the person who intervenes and records the outcomes.</study_design>
      <phase>3</phase>
      <hc_freetext>Thoracic surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group after induction of anesthesia and tracheal intubation with a left double lumen  endotracheal tube, with the start of surgery, one-lung pressure control ventilation will begin for patients with the following characteristics: airway pressure = 20 cmH2O, respiratory rate = 12/min, to achieve the ideal tidal volume of 6 ml/kg gradual changes in airway pressure will be used. To achieve proper minute ventilation and maintain end-tidal carbon dioxide (ET-Co2) pressure in the range of 35-40 mmhg, the respiratory rate will be changed. For mechanical ventilation of patients the anesthesia machine model EDP-Neptune MEDEC made in Belgium is used. Intervention 2: Control group: In the control group, after induction of anesthesia, the patient was intubated with a left double lumen  endotracheal tube. At the beginning of the surgery, one-lung volume control ventilation is started for patients with the following characteristics: tidal volume of 6 ml/kg and a respiratory rate of 12 per minute. A change in respiration rate will be used to achieve proper minute ventilation and maintain expiratory carbon dixide  pressure in the range of 35-40 mmhg. For mechanical ventilation of patients, the anesthesia machine model EDP-Neptune MEDEC made in Belgium is used.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Reza Ghodraty</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Anesthesia Department, Firoozgar Hospital, Behafarin St. Karim Khan Av.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8874113911</zip>
        <telephone>+98 21 8894 6762</telephone>
        <email>ghodrati.mr@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Reza Ghodraty</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Anesthesia Department, Firoozgar Hospital, Behafarin St. Karim Khan Av.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8874113911</zip>
        <telephone>+98 21 8894 6762</telephone>
        <email>ghodrati.mr@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients candidates for thoracic surgery under one-lung ventilation
ASA physical class &lt; or = class III
Patients with a body mass index between 20 - 35</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Severe preoperative hypoxemia (SPo2 lower than 88% with room air)
Patient dissatisfaction</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group after induction of anesthesia and tracheal intubation with a left double lumen  endotracheal tube, with the start of surgery, one-lung pressure control ventilation will begin for patients with the following characteristics: airway pressure = 20 cmH2O, respiratory rate = 12/min, to achieve the ideal tidal volume of 6 ml/kg gradual changes in airway pressure will be used. To achieve proper minute ventilation and maintain end-tidal carbon dioxide (ET-Co2) pressure in the range of 35-40 mmhg, the respiratory rate will be changed. For mechanical ventilation of patients the anesthesia machine model EDP-Neptune MEDEC made in Belgium is used.</i_keyword>
      <i_keyword>Control group: In the control group, after induction of anesthesia, the patient was intubated with a left double lumen  endotracheal tube. At the beginning of the surgery, one-lung volume control ventilation is started for patients with the following characteristics: tidal volume of 6 ml/kg and a respiratory rate of 12 per minute. A change in respiration rate will be used to achieve proper minute ventilation and maintain expiratory carbon dixide  pressure in the range of 35-40 mmhg. For mechanical ventilation of patients, the anesthesia machine model EDP-Neptune MEDEC made in Belgium is used.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Arterial blood oxygen pressure (PaO2). Timepoint: Before starting one-lung ventilation and for second time, 30 min after start of one-lung ventilation. Method of measurement: Arterial blood gas analysis.</prim_outcome>
      <prim_outcome>Peak airway pressure. Timepoint: After tracheal intubation and then every 15 min during one-lung ventilation. Method of measurement: By airway pressure monitoring device included in anesthesia machine.</prim_outcome>
      <prim_outcome>End-tidal pressure of CO2. Timepoint: Every 15 min during surgery. Method of measurement: By Capnograph monitoring.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Dynamic compliance of respiratory system. Timepoint: After tracheal intubation and then every 15 min during one-lung ventilation. Method of measurement: Using the standard formula and tidal volume divided in airway pressure.</sec_outcome>
      <sec_outcome>Respiratory dead space. Timepoint: After tracheal intubation and then 30 min after one-lung ventilation starting. Method of measurement: Calculation by the use of arterial and end tidal PCo2 pressure.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-04</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Hemmat Highway next to Milad Tower, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
